Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4939) 4939
Book Review (1339) 1339
Publication (432) 432
Book / eBook (160) 160
Book Chapter (127) 127
Conference Proceeding (16) 16
Magazine Article (11) 11
Newspaper Article (10) 10
Dissertation (5) 5
Government Document (4) 4
Web Resource (3) 3
Data Set (1) 1
Journal / eJournal (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3880) 3880
humans (3839) 3839
female (1946) 1946
male (1919) 1919
familial primary pulmonary hypertension (1574) 1574
adult (1261) 1261
pulmonary hypertension (1252) 1252
middle aged (1179) 1179
cardiac & cardiovascular systems (996) 996
respiratory system (967) 967
hypertension, pulmonary - physiopathology (799) 799
animals (786) 786
primary pulmonary-hypertension (784) 784
hypertension (762) 762
abridged index medicus (759) 759
aged (670) 670
hypertension, pulmonary - drug therapy (593) 593
treatment outcome (542) 542
pulmonary arterial hypertension (500) 500
survival (493) 493
primary pulmonary hypertension (492) 492
diagnosis (484) 484
risk factors (484) 484
hypertension, pulmonary - diagnosis (461) 461
prognosis (445) 445
disease (430) 430
retrospective studies (426) 426
hypertension, pulmonary - etiology (419) 419
medicine & public health (415) 415
medicine, general & internal (415) 415
surgery (378) 378
care and treatment (375) 375
therapy (374) 374
adolescent (368) 368
child (363) 363
mortality (333) 333
heart (327) 327
echocardiography (321) 321
research (311) 311
transplantation (310) 310
internal medicine (309) 309
health aspects (302) 302
lung transplantation (296) 296
hypertension, pulmonary - complications (294) 294
peripheral vascular disease (294) 294
time factors (289) 289
arterial-hypertension (282) 282
analysis (281) 281
primary health care (280) 280
young adult (278) 278
rats (276) 276
pediatrics (271) 271
follow-up studies (262) 262
hemodynamics (259) 259
pharmacology & pharmacy (259) 259
antihypertensive agents - therapeutic use (256) 256
cardiology (256) 256
lung (248) 248
hypertension, pulmonary - pathology (247) 247
heart failure (239) 239
primary care (236) 236
hypertension, pulmonary - therapy (233) 233
pulmonary artery - physiopathology (232) 232
prostacyclin (226) 226
hypertension, pulmonary - metabolism (225) 225
severity of illness index (222) 222
expression (221) 221
pulmonary arteries (217) 217
children (211) 211
critical care medicine (211) 211
hypertension, pulmonary - genetics (208) 208
cardiovascular (203) 203
hypertension, pulmonary - mortality (203) 203
mice (201) 201
management (200) 200
child, preschool (199) 199
article (191) 191
hematology (190) 190
hypertension, pulmonary (190) 190
prospective studies (189) 189
prevalence (187) 187
rheumatology (184) 184
infant (183) 183
drug therapy (181) 181
medicine (178) 178
smooth-muscle-cells (177) 177
patients (175) 175
blood pressure (172) 172
disease models, animal (171) 171
case-control studies (169) 169
primary graft dysfunction (169) 169
physiology (167) 167
mutation (166) 166
cardiac catheterization (164) 164
immunology (164) 164
physiological aspects (161) 161
cell biology (160) 160
predictive value of tests (159) 159
pulmonary artery - pathology (158) 158
cells, cultured (157) 157
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (108) 108
Collection Dvlpm't (Acquisitions) - Closed Orders (11) 11
Scarborough Hospital - General (11) 11
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (8) 8
Women's College Hospital - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Lakeridge Health Sciences - Oshawa (4) 4
St. Michael's Hospital - Stacks (4) 4
Credit Valley Hospital - Stacks (2) 2
Holland Bloorview Kids Rehabilitation - Stacks (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Online Resources - Online (2) 2
Trillium Health Centre - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Credit Valley Hospital - Reserve desk (1) 1
Earth Sciences (Noranda) - Missing (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Missing (1) 1
Humber River Regional Hospital - Keele Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Pharmacy (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Hospital Department (1) 1
St Josephs Health Centre - Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Toronto East General Hospital - Online (1) 1
Trillium Health Centre - Reserve desk (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4893) 4893
French (64) 64
German (56) 56
Chinese (50) 50
Russian (46) 46
Spanish (46) 46
Japanese (31) 31
Korean (15) 15
Polish (15) 15
Turkish (10) 10
Italian (9) 9
Portuguese (5) 5
Czech (4) 4
Romanian (3) 3
Hebrew (2) 2
Norwegian (2) 2
Swedish (2) 2
Albanian (1) 1
Arabic (1) 1
Dutch (1) 1
Hungarian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Pulmonary Hypertension
by Shah, Sanjiv J
JAMA, ISSN 0098-7484, 10/2012, Volume 308, Issue 13, pp. 1366 - 1374
Pulmonary hypertension (PH), defined as elevated pulmonary artery pressure, is common in the general population and associated with increased mortality.... 
MEDICINE, GENERAL & INTERNAL | ARTERY SYSTOLIC PRESSURE | CONTROLLED TRIAL | RIGHT-VENTRICULAR FUNCTION | CARDIOVASCULAR-DISEASE | PRESERVED EJECTION FRACTION | SICKLE-CELL-DISEASE | CAPILLARY WEDGE PRESSURE | RIGHT HEART CATHETERIZATION | VASCULAR-DISEASE | DOPPLER-ECHOCARDIOGRAPHY | Echocardiography | Hypertension, Pulmonary - classification | Prognosis | Vasodilator Agents - therapeutic use | Humans | Pulmonary Veins - physiopathology | Hypertension, Pulmonary - diagnostic imaging | Ventricular Dysfunction, Left - complications | Familial Primary Pulmonary Hypertension | Algorithms | Female | Aged | Hypertension, Pulmonary - drug therapy | Vasodilator Agents - adverse effects | Hypertension, Pulmonary - pathology | Ventricular Function, Right | Hypertension, Pulmonary - complications | Heart failure | Care and treatment | Medical case management | Causes of | Diagnosis | Methods | Pulmonary hypertension | Risk factors | Hypertension | Medical research | Ultrasonic imaging | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Primary pulmonary hypertension
by Rich, Stuart and Rubin, Lewis J
1997, ISBN 9780824795054, Volume 99., xvii, 358
Pulmonary hypertension
Book
Details down arrow
3. Full Text Pulmonary hypertension with warm hands
by Botros, Liza and Aman, Jurjan and Bogaard, Harm Jan and Vonk Noordegraaf, Anton
Thorax, ISSN 0040-6376, 12/2017, Volume 72, Issue 12, pp. 1164 - 1166
Carbon monoxide diffusion capacity (DLCO) was 97.64 [mu]mol/s/kPa (60%) and 6 min walking distance was 370 m with no drop in SpO2. Because of the suspicion of... 
Primary Pulmonary Hypertension | POLYCYTHEMIA | RESPIRATORY SYSTEM | MUTATION | Heart | Congenital diseases | Pulmonary arteries | Lung diseases | Iron | Family medical history | Patients | Thrombosis | Pulmonary hypertension | Defects | Hypoxia | Mutation | Thromboembolism | Veins & arteries | Index Medicus | Chest Clinic | 1506
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Recent trends in the management of pulmonary hypertension
by Prabhu, Manuru Mukhyaprana and Kiran, Hasan Sreenivas Murthy Kiran and Palaian, Subish and Vidyasagar, Sudha
Recent trends in the management of pulmonary hypertension, 12/2005
Context. Pulmonary hypertension is a common clinical problem encountered in day-to-day practice. Drug therapy forms the backbone of management and appropriate... 
Primary and Secondary Pulmonary Hypertension, Treatment options, Prostacyclin analogues, Bosentan, Sildanafil
Journal
Details down arrow
5. Full Text Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice
by Aliotta, Jason M and Pereira, Mandy and Wen, Sicheng and Dooner, Mark S and Del Tatto, Michael and Papa, Elaine and Goldberg, Laura R and Baird, Grayson L and Ventetuolo, Corey E and Quesenberry, Peter J and Klinger, James R
Cardiovascular Research, ISSN 0008-6363, 06/2016, Volume 110, Issue 3, pp. 319 - 330
Extracellular vesicles (EVs) from mice with monocrotaline (MCT)-induced pulmonary hypertension (PH) induce PH in healthy mice, and the exosomes (EXO) fraction... 
Extracellular vesicles | MicroRNA | Exosomes | Pulmonary hypertension | Mesenchymal stem cells | CELLS | LUNG | CARDIAC & CARDIOVASCULAR SYSTEMS | PHENOTYPE | RECEPTOR | MICROVESICLES | BETA | PATHOGENESIS | INVASION | GENE-EXPRESSION | Vascular Remodeling | Humans | Monocrotaline | Cell-Derived Microparticles - transplantation | Hypertension, Pulmonary - physiopathology | Exosomes - genetics | Male | Hypertension, Pulmonary - chemically induced | Case-Control Studies | Familial Primary Pulmonary Hypertension - physiopathology | Hypertension, Pulmonary - prevention & control | Pulmonary Artery - metabolism | Cell-Derived Microparticles - metabolism | Hypertrophy, Right Ventricular - genetics | Disease Models, Animal | Exosomes - transplantation | Mice, Inbred C57BL | Cells, Cultured | Gene Expression Regulation | Mesenchymal Stromal Cells - metabolism | Familial Primary Pulmonary Hypertension - genetics | Hypertension, Pulmonary - genetics | Pulmonary Artery - physiopathology | Animals | Hypertrophy, Right Ventricular - chemically induced | Hypertrophy, Right Ventricular - prevention & control | MicroRNAs - genetics | Mesenchymal Stem Cell Transplantation | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort
by Strange, Geoff and Playford, David and Stewart, Simon and Deague, Jenny A and Nelson, Helen and Kent, Aaron and Gabbay, Eli
Heart, ISSN 1355-6037, 12/2012, Volume 98, Issue 24, pp. 1805 - 1811
Background Pulmonary hypertension (PHT) lacks community prevalence and outcome data. Objective To characterise minimum ‘indicative’ prevalences and mortality... 
DIAGNOSIS | ARTERY SYSTOLIC PRESSURE | CARDIAC & CARDIOVASCULAR SYSTEMS | SOCIETY-OF-CARDIOLOGY | RECOMMENDATIONS | PROSTACYCLIN | GUIDELINES | CLASSIFICATION | SYSTEMIC-SCLEROSIS | REGISTRY | BOSENTAN | Severity of Illness Index | Echocardiography | Prevalence | Prognosis | Survival Rate - trends | Humans | Middle Aged | Hypertension, Pulmonary - diagnostic imaging | Hypertension, Pulmonary - physiopathology | Familial Primary Pulmonary Hypertension | Male | Hypertension, Pulmonary - epidemiology | Pulmonary Wedge Pressure - physiology | Adult | Female | Aged | Western Australia - epidemiology | Studies | Heart | Pulmonary arteries | Laboratories | Mortality | Cardiovascular disease | Population | Software | Data bases | Pulmonary hypertension | Veins & arteries | Index Medicus | Abridged Index Medicus | heart failure | st-T alterations | echocardiography | imaging and diagnostics | chronic heart failure | pulmonary vascular disease | cardiopulmonary haemodynamics | lung | prevalence | epidemiology | atrial fibrillation | arrhythmias | PAH | 1507 | Original | 1506 | pulmonary arterial hypertension | public health
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Pulmonary Hypertension
by Newman, John H
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 11/2005, Volume 172, Issue 9, pp. 1072 - 1077
The modern era in cardiopulmonary medicine began in the 1940s, when Cournand and Richards pioneered right-heart catheterization. Until that time, no direct... 
Primary pulmonary hypertension | High altitude | Pulmonary arterial hypertension | Hypoxic vasoconstriction | Thromboembolism | LUNG | high altitude | thromboembolism | PROSTACYCLIN | COR-PULMONALE | hypoxic vasoconstriction | RECEPTOR | primary pulmonary hypertension | HEART | THROMBOTIC OBSTRUCTION | RESPIRATORY SYSTEM | ARTERIAL-HYPERTENSION | MUTATIONS | OXYGEN-THERAPY | pulmonary arterial hypertension | VASOCONSTRICTION | CRITICAL CARE MEDICINE | Hypertension, Pulmonary - diagnosis | Respiratory Therapy - history | Diagnostic Techniques, Respiratory System - instrumentation | History, 20th Century | Humans | Hypertension, Pulmonary - history | Diagnostic Techniques, Respiratory System - history | Hypertension, Pulmonary - therapy | Index Medicus | Abridged Index Medicus | Centennial Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Pulmonary hypertension associated with benfluorex exposure
by Savale, Laurent and Chaumais, Marie-Camille and Cottin, Vincent and Bergot, Emmanuel and Frachon, Irène and Prevot, Grégoire and Pison, Christophe and Dromer, Claire and Poubeau, Patrice and Lamblin, Nicolas and Habib, Gilbert and Reynaud-Gaubert, Martine and Bourdin, Arnaud and Sanchez, Olivier and Tubert-Bitter, Pascale and Jaïs, Xavier and Montani, David and Sitbon, Olivier and Simonneau, Gérald and Humbert, Marc
European Respiratory Journal, ISSN 0903-1936, 11/2012, Volume 40, Issue 5, pp. 1164 - 1172
Benfluorex was marketed in France until 2009, despite its similar pharmacological properties with fenfluramine and its derivatives known to be a cause of... 
Valvular heart disease | Fenfluramine derivates | Benfluorex | Pulmonary hypertension | Anorectic agents | ANOREXIGEN AMINOREX | pulmonary hypertension | GUIDELINES | VALVULAR HEART-DISEASE | LESSONS | benfluorex | fenfluramine derivates | RESPIRATORY SYSTEM | ARTERIAL-HYPERTENSION | valvular heart disease | VASCULAR ORIGIN | MUTATIONS | FENFLURAMINE | EPIDEMIC | ARTERIOPATHY | Appetite Depressants - adverse effects | Fenfluramine - analogs & derivatives | Humans | Middle Aged | Adult | Familial Primary Pulmonary Hypertension | Female | Male | Aged | Fenfluramine - adverse effects | Retrospective Studies | Hypertension, Pulmonary - chemically induced | Index Medicus | Life Sciences | Appetite Depressants | Fenfluramine | Hypertension, Pulmonary
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Pulmonary Hypertension: Diagnosis and Treatment
by Dunlap, Beth, MD and Weyer, George, MD
American Family Physician, ISSN 0002-838X, 2016, Volume 94, Issue 6, pp. 463 - 469
Pulmonary hypertension is a common, complex group of disorders that result from different pathophysiologic mechanisms but are all defined by a mean pulmonary... 
Internal Medicine | UNITED-STATES | HEART | PRESSURE | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | TASK-FORCE | RISK STRATIFICATION | ARTERIAL-HYPERTENSION | PRIMARY HEALTH CARE | SICKLE-CELL-DISEASE | ASSOCIATION | GUIDELINE | Electrocardiography | Hypertension, Pulmonary - physiopathology | Hypertension, Pulmonary - diagnosis | Humans | Hypertension, Pulmonary - therapy | Practice Guidelines as Topic | Cardiac catheterization | Usage | Care and treatment | Echocardiography | Diagnosis | Pulmonary hypertension | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Genetic counselling in a national referral centre for pulmonary hypertension
by Girerd, Barbara and Montani, David and Jaïs, Xavier and Eyries, Mélanie and Yaici, Azzedine and Sztrymf, Benjamin and Savale, Laurent and Parent, Florence and Coulet, Florence and Godinas, Laurent and Lau, Edmund M and Tamura, Yuichi and Sitbon, Olivier and Soubrier, Florent and Simonneau, Gérald and Humbert, Marc
European Respiratory Journal, ISSN 0903-1936, 02/2016, Volume 47, Issue 2, pp. 541 - 552
Genetic causes of pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease (PVOD) have been identified, leading to a growing need for genetic... 
SURVIVAL | DIAGNOSIS | GENOMICS | BMPR2 MUTATION | VENOOCCLUSIVE DISEASE | RESPIRATORY SYSTEM | ARTERIAL-HYPERTENSION | GERMLINE MUTATIONS | RECEPTOR | CARRIERS | CLINICAL-OUTCOMES | Smad8 Protein - genetics | Humans | Preimplantation Diagnosis | Male | Asymptomatic Diseases | Antigens, CD - genetics | Genetic Testing - methods | Endoglin | Pulmonary Veno-Occlusive Disease - genetics | Adult | Female | France | Tertiary Care Centers | Bone Morphogenetic Protein Receptors, Type II - genetics | Protein-Serine-Threonine Kinases - genetics | Caveolin 1 - genetics | Genetic Counseling - methods | Potassium Channels, Tandem Pore Domain - genetics | Familial Primary Pulmonary Hypertension - genetics | Hypertension, Pulmonary - genetics | Nerve Tissue Proteins - genetics | Activin Receptors, Type II - genetics | Family | Mutation | Receptors, Cell Surface - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Hemodynamic Thresholds for Precapillary Pulmonary Hypertension
by Gerges, Christian, MD and Gerges, Mario, MD and Skoro-Sajer, Nika, MD and Zhou, Yi, PhD and Zhang, Lixia, PhD and Sadushi-Kolici, Roela, MD and Jakowitsch, Johannes, PhD and Lang, Marie B., MD and Lang, Irene M., MD
Chest, ISSN 0012-3692, 2016, Volume 149, Issue 4, pp. 1061 - 1073
Background Hemodynamic differentiation between pulmonary arterial hypertension (PAH) and postcapillary pulmonary hypertension (PH) is important because... 
Pulmonary/Respiratory | heart failure | pulmonary circulation | pulmonary hypertension | hemodynamics | Heart failure | Pulmonary circulation | Hemodynamics | Pulmonary hypertension | Diagnosis, Differential | Hypertension, Pulmonary - diagnosis | Vascular Resistance | Humans | Middle Aged | Familial Primary Pulmonary Hypertension - drug therapy | Proportional Hazards Models | Pulmonary Wedge Pressure | Male | Familial Primary Pulmonary Hypertension - diagnosis | Antihypertensive Agents - therapeutic use | Pulmonary Circulation | Epoprostenol - therapeutic use | Cardiac Catheterization | Epoprostenol - analogs & derivatives | Adult | Female | ROC Curve | Aged | Retrospective Studies | Cohort Studies | Databases, Factual | Usage | Care and treatment | Analysis | Prostacyclin | Research | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension
by Mizoguchi, Hiroki and Ogawa, Aiko and Munemasa, Mitsuru and Mikouchi, Hiroshi and Ito, Hiroshi and Matsubara, Hiromi
Circulation: Cardiovascular Interventions, ISSN 1941-7640, 12/2012, Volume 5, Issue 6, pp. 748 - 755
Background-Although balloon pulmonary angioplasty (BPA) for inoperable patients with chronic thromboembolic pulmonary hypertension was first reported over a... 
Peripheral vascular disease | Reperfusion | Pulmonary hypertension | Revascularization | EMBOLISM | revascularization | CARDIAC & CARDIOVASCULAR SYSTEMS | pulmonary hypertension | LUNG INJURY | reperfusion | peripheral vascular disease | INTERNATIONAL PROSPECTIVE REGISTRY | ENDARTERECTOMY | Reperfusion Injury - etiology | Hypertension, Pulmonary - diagnosis | Humans | Middle Aged | Ultrasonography, Interventional | Hypertension, Pulmonary - physiopathology | Male | Pulmonary Embolism - therapy | Pulmonary Artery - diagnostic imaging | Angioplasty, Balloon - adverse effects | Hypertension, Pulmonary - therapy | Recovery of Function | Cardiac Catheterization | Arterial Pressure | Pneumonia - mortality | Time Factors | Aged, 80 and over | Adult | Female | Heart Failure - etiology | Angioplasty, Balloon - methods | Heart Failure - mortality | Hypertension, Pulmonary - mortality | Pulmonary Embolism - complications | Reperfusion Injury - therapy | Pneumonia - etiology | Familial Primary Pulmonary Hypertension | Linear Models | Treatment Outcome | Pulmonary Artery - physiopathology | Respiration, Artificial | Pulmonary Embolism - mortality | Radiography | Pulmonary Embolism - diagnosis | Angioplasty, Balloon - mortality | Aged | Chronic Disease | Hypertension, Pulmonary - etiology | Pulmonary Embolism - physiopathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text How does inflammation contribute to pulmonary hypertension?
by Kumar, Rahul and Kumar, Rahul and Graham, Brian and Graham, Brian
The European respiratory journal, ISSN 0903-1936, 01/2018, Volume 51, Issue 1, pp. 1702403 - 1702403
Pathogenic drivers of the pulmonary vascular disease that results in pulmonary arterial hypertension (PAH) are currently unclear, but there are many reasons to... 
IMMUNE | RECRUITMENT | CELLS | LUNG | SCHISTOSOMIASIS | RESPIRATORY SYSTEM | MACROPHAGES | ARTERIAL-HYPERTENSION | SYSTEMIC-SCLEROSIS | Familial Primary Pulmonary Hypertension | Hypertension, Pulmonary | Inflammation | Pulmonary Artery | Humans | Hypertension | Schistosomiasis | Systemic lupus erythematosus | Infectious diseases | Vascular diseases | Ischemia | Lung diseases | Scleroderma | Autoimmune diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005
by van Loon, Rosa Laura E and Roofthooft, Marcus T. R and Hillege, Hans L and ten Harkel, Arend D. J and van Osch-Gevers, Magdalena and Delhaas, Tammo and Kapusta, Livia and Strengers, Jan L. M and Rammeloo, Lukas and Clur, Sally-Ann B and Mulder, Barbara J. M and Berger, Rolf M. F
Circulation, ISSN 0009-7322, 2011, Volume 124, Issue 16, pp. 1755 - 1764
Incidence and prevalence rates for pediatric pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH) are unknown. This study describes the... 
SURVIVAL | CARDIAC & CARDIOVASCULAR SYSTEMS | pulmonary hypertension | EISENMENGER-SYNDROME | ADULTS | CLASSIFICATION | pediatric | CHILDREN | epidemiology | prevalence | HEART-DISEASE | ARTERIAL-HYPERTENSION | CONGENITAL CARDIAC-DISEASE | PERIPHERAL VASCULAR DISEASE | incidence | REGISTRY | Age Factors | Humans | Netherlands - epidemiology | Child, Preschool | Familial Primary Pulmonary Hypertension | Infant | Hypertension, Pulmonary - epidemiology | Incidence | Heart Defects, Congenital - complications | Adolescent | Heart Defects, Congenital - epidemiology | Registries | Retrospective Studies | Child | Hypertension, Pulmonary - etiology | Infant, Newborn | Research | Children | Demographic aspects | Pulmonary hypertension | Distribution | Diseases | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Genetic analyses in a cohort of children with pulmonary hypertension
by Levy, Marilyne and Eyries, Mélanie and Szezepanski, Isabelle and Ladouceur, Magalie and Nadaud, Sophie and Bonnet, Damien and Soubrier, Florent
European Respiratory Journal, ISSN 0903-1936, 10/2016, Volume 48, Issue 4, pp. 1118 - 1126
The prevalence of germline mutations in paediatric pulmonary hypertension (PH) is poorly documented. The objective of this study was to determine the mutation... 
BMPR2 MUTATION | ALK1 MUTATION | RESPIRATORY SYSTEM | CONGENITAL HEART-DISEASE | ARTERIAL-HYPERTENSION | CHILDHOOD | CARRIERS | CLINICAL-OUTCOMES | REGISTRY | Pulmonary Veno-Occlusive Disease - diagnosis | Humans | Child, Preschool | Male | Familial Primary Pulmonary Hypertension - diagnosis | Heart Defects, Congenital - genetics | Pulmonary Veno-Occlusive Disease - genetics | DNA Mutational Analysis | Female | Child | Pulmonary Veno-Occlusive Disease - complications | Genetic Predisposition to Disease | Bone Morphogenetic Protein Receptors, Type II - genetics | Familial Primary Pulmonary Hypertension - genetics | Treatment Outcome | T-Box Domain Proteins - genetics | Heart Defects, Congenital - complications | Pedigree | Activin Receptors, Type II - genetics | Adolescent | Heart Defects, Congenital - diagnosis | Heterozygote | Hemodynamics | Mutation | Cohort Studies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text PAR-2 Inhibition Reverses Experimental Pulmonary Hypertension
by Kwapiszewska, Grazyna and Markart, Philipp and Dahal, Bhola Kumar and Kojonazarov, Baktybek and Marsh, Leigh Matthew and Schermuly, Ralph Theo and Taube, Christian and Meinhardt, Andreas and Ghofrani, Hossein Ardeschir and Steinhoff, Martin and Seeger, Werner and Preissner, Klaus Theo and Olschewski, Andrea and Weissmann, Norbert and Wygrecka, Malgorzata
Circulation Research, ISSN 0009-7330, 04/2012, Volume 110, Issue 9, pp. 1179 - 1191
RATIONALE:A hallmark of the vascular remodeling process underlying pulmonary hypertension (PH) is the aberrant proliferation and migration of pulmonary... 
Mast cells | Pulmonary arterial hypertension | Protease-activated receptor-2 | FACTOR XA | CARDIAC & CARDIOVASCULAR SYSTEMS | RATS | mast cells | SMOOTH-MUSCLE CELL | MITOGEN | CHRONIC HYPOXIA | INFLAMMATION | ARTERIAL-HYPERTENSION | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | pulmonary arterial hypertension | EXPRESSION | MAST-CELL TRYPTASE | protease-activated receptor-2 | Cell Proliferation | Humans | Middle Aged | Monocrotaline | Male | Hypertension, Pulmonary - therapy | Young Adult | Pulmonary Artery - metabolism | RNA Interference | Time Factors | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Myocytes, Smooth Muscle - drug effects | Disease Models, Animal | Muscle, Smooth, Vascular - drug effects | Receptor, PAR-2 - genetics | Receptor, Platelet-Derived Growth Factor beta - metabolism | Signal Transduction | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Rats | Familial Primary Pulmonary Hypertension | Hypoxia - complications | Pulmonary Artery - drug effects | Pyrimidines - pharmacology | Piperazines - pharmacology | Rats, Sprague-Dawley | Mice, Knockout | Adolescent | Ligands | Mice | Oligopeptides - pharmacology | Hypertension, Pulmonary - etiology | Cell Movement | Tryptases - metabolism | Muscle, Smooth, Vascular - metabolism | Receptor, PAR-2 - metabolism | Myocytes, Smooth Muscle - pathology | Receptor, PAR-2 - deficiency | Receptor, PAR-2 - antagonists & inhibitors | Receptor, Platelet-Derived Growth Factor beta - antagonists & inhibitors | Transfection | Adult | Female | Myocytes, Smooth Muscle - metabolism | Proto-Oncogene Proteins c-sis - metabolism | Mice, Inbred C57BL | Cells, Cultured | Antibodies, Neutralizing - pharmacology | Hypertension, Pulmonary - genetics | Hypertension, Pulmonary - metabolism | Imatinib Mesylate | Proto-Oncogene Proteins c-sis - immunology | Muscle, Smooth, Vascular - pathology | Animals | Benzamides | Hypertension, Pulmonary - pathology | Pulmonary Artery - pathology | Proto-Oncogene Proteins c-sis - antagonists & inhibitors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Haemodynamic unloading reverses occlusive vascular lesions in severe pulmonary hypertension
by Abe, Kohtaro and Shinoda, Masako and Tanaka, Mariko and Kuwabara, Yukimitsu and Yoshida, Keimei and Hirooka, Yoshitaka and McMurtry, Ivan F and Oka, Masahiko and Sunagawa, Kenji
Cardiovascular Research, ISSN 0008-6363, 2016, Volume 111, Issue 1, pp. 16 - 25
An important pathogenic mechanism in the development of idiopathic pulmonary arterial hypertension is hypothesized to be a cancer-like cellular proliferation... 
Haemodynamic stress | Occlusive lesion formation | Pulmonary arterial hypertension | REGRESSION | SURVIVAL | CARDIAC & CARDIOVASCULAR SYSTEMS | RATS | BLOOD-FLOW | SINGLE-LUNG TRANSPLANTATION | CHRONIC HYPOXIA | INFLAMMATION | ARTERIAL-HYPERTENSION | PLEXIFORM LESIONS | ENDOTHELIAL-CELL GROWTH | Inflammation - pathology | Vascular Remodeling | Cell Proliferation | Familial Primary Pulmonary Hypertension - etiology | Male | Pulmonary Artery - surgery | Familial Primary Pulmonary Hypertension - metabolism | Familial Primary Pulmonary Hypertension - physiopathology | Inflammation - metabolism | Pulmonary Artery - metabolism | Ligation | Neointima | Arterial Occlusive Diseases - pathology | Inflammation Mediators - metabolism | Arterial Occlusive Diseases - physiopathology | Cytokines - genetics | Disease Models, Animal | Familial Primary Pulmonary Hypertension - pathology | Severity of Illness Index | Cytokines - metabolism | Hypoxia - complications | Pulmonary Artery - physiopathology | Angiogenesis Inhibitors | Inflammation - etiology | Rats, Sprague-Dawley | Arterial Occlusive Diseases - etiology | Pulmonary Circulation | Animals | Transcription Factor RelA - metabolism | Arterial Occlusive Diseases - metabolism | Hemodynamics | Pulmonary Artery - pathology | Inflammation - physiopathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights